RayanaAI
Account
BLCO
HOLD / NEUTRALMeanRev
Composite
62.60
Technical
84.40
Fundamental
55.40
Rank
—
Price
20.40
Hurst
0.24
As of
Oct 30, 2026
DailyTurtleMean-reversion
Bausch + Lomb Corporation
HealthcareMedical Instruments & Supplies

Bausch + Lomb Corporation is an eye health company operating across the United States, Canada, and multiple international markets through three business segments. The Vision Care segment manufactures contact lenses for various wearing schedules and therapeutic applications, along with lens care solutions, eye vitamins, and over-the-counter drops for conditions like dry eye and allergies. The Pharmaceuticals segment develops drugs for post-operative care, glaucoma, inflammation, and retinal diseases, while the Surgical segment produces equipment, devices, and instruments used in cataract and corneal procedures. The company distributes its products through direct sales teams and independent distributors worldwide.

Market cap
$7.1B
P/E (trailing)
—
P/E (forward)
16.75
PEG ratio
0.89
Dividend yield
0.00%
Beta
0.56
52w range
14.44 – 21.36
Return on equity
-1.58%
Profit margin
-2.05%
Revenue growth
+7.30%
Earnings growth
—
Price history

1Y: 20.00 (+33.9%) · range 14.56–20.40

Cycle position
72/ 100 cycle scoreAPPROACHING EXIT
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 13 · NOT READY · exit proximity 35

Conviction
41/ 100 · maturity 43%
VScore.2236
Buildup.2670
EMA entry setup.3213
Fundamentals.1955
Volume profile
POC
16.19
Price vs POC
+26.0%
Overhead supply
5%
Runway
open sky

Value area 15.32–17.47 · 5% of 120d volume overhead · clean runway

Contributing sources
SourceScoreLast seen
earnings-surprise
0.933
Oct 30, 2026
trend-signal
0.000
Oct 29, 2026
Pattern & cluster
Pattern
NEUTRAL
Cluster
CONFIRM
Forward returns

Not yet labeled — the study prices these as positions mature.